Tom Greenhalgh

By day, Tom Greenhalgh is an author for more than a dozen medical brands, where he writes easily-digestible content for clinicians and patients alike on medical breakthroughs and hot button issues. By night, he is an amateur music producer, avid sports fan, and Netflix connoisseur. Find him on LinkedIn or email him.

All articles by Tom Greenhalgh

The high cost of CAR-T therapy concerns patient advocates who worry about the "financial toxicity" i

The Cost of Cancer Treatment: Financial Toxicity in Acute Leukemia

By

Tom Greenhalgh

May 10, 2019

What is the role of the clinician in managing financial toxicity?

Approaching leukemia today as only a “liquid” cancer in all cases is to overlook knowledge long avai

Leukemia: What Your Patients Need to Know

By

Tom Greenhalgh

April 25, 2019

Your patients may have questions about leukemia. Help them better understand the condition by sharing this article with them.

Next post in Leukemia

A DNA helix against a black background.

Effects of HLA Dimorphism on Clinical Outcomes of Immunotherapy in Acute Myeloid Leukemia